In January 2018, Jasmine was diagnosed with high-risk neuroblastoma. Her family are desperate to do all they can to give Jasmine the best chance of beating this awful disease and are launching an appeal to raise £236,000.

The vital funds we are hoping to raise for Jasmine will allow her access the Bivalent Vaccine as soon as she finishes Frontline treatment, in New York which is showing promising results in reducing the likelihood of a relapse and her best chance at remaining cancer-free.